[1]
“Evaluating The Real-World Effectiveness Of A New Class Of Drugs For Cystic Fibrosis: A Study Based On European Cystic Fibrosis Society Patient Registry Data”, ebph, Sep. 2025, doi: 10.54103/2282-0930/29286.